ROCK (Rho-associated protein kinase) inhibitors are a group of compounds that target the ROCK signaling pathway, crucial in regulating the actin cytoskeleton and cellular motility. By inhibiting ROCK, these molecules have shown promise in treating conditions involving aberrant cell motility, like cancer metastasis and fibrosis. They are under investigation for their therapeutic potential in various diseases, particularly those involving tissue remodeling and cell migration.